Boehringer Ingelheim Launches Hepatitis C Website
November 13, 2012
On November 9, pharmaceutical company Boehringer Ingelheim announced the launch of a website -- HepCRedefined.com -- that is designed for patients with hepatitis C and their advocates. The company describes the website as an online portal designed to improve the lives of those living with the virus through education, information, and understanding. According to Hepatitis Education Project Executive Director Michael Ninburg, the HCV community needs the resources to talk about the disease in an informed way. "HepCRedefined.com is designed to aggregate straightforward and accurate information in a single virtual destination," he explained.
Drug Store News
11.09.2012; Alaric Dearment
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)